跳至主要内容
临床试验/EUCTR2004-003814-40-HU
EUCTR2004-003814-40-HU进行中(未招募)不适用

An open-label, multi-centre, extension study evaluation the long-term safety and tolerability of Degarelix one-month depots in patients with prostate cancer

Ferring Pharmaceuticals A/S0 个研究点目标入组 130 人开始时间: 2004年11月9日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
130

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Has given written consent prior to any study-related activity is performed. A study-related activity is defined as any procedure that would not have been performed during the normal management of the patient.
  • Has completed the FE200486 CS12 study
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Has been withdrawn from the FE200486 CS12 study

研究者

相似试验